← Evidence map

ArticleInfectious diseases and therapy2026

Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study.

Jinghao Nicholas Ngiam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study. | Socratic